How do I run my first peptide cycle, step by step?

The short answer

A first peptide cycle is a sequence of deliberate steps, not a leap: pick a compound for a defined goal, source and verify it, reconstitute and calculate your dose, inject with sterile technique, track the effect, and decide at the end whether it did what you wanted. Doing each step carefully is what separates a sensible first cycle from a risky guess.

Evidence tier: This is Tier 3–4 — a practical walkthrough, not a clinical protocol. The process and safety principles are well-established; specific compounds, doses, and durations depend on your situation and ideally a clinician.

The essentials:

• Start with a defined goal, then pick the compound — not the reverse.
• Source, verify, and do the dosing math before your first injection.
• Run a sensible duration and track the effect honestly.
• Evaluate at the end — did it work, and what next?

This is a step-by-step companion to our peptide beginner's guide. For the safety foundation see the peptide safety and sourcing guide.

Step 1: define the goal, then choose the compound

Evidence tier: 3–4 — goal-first selection.

The right starting point is a specific, honest goal — "heal this tendon," "improve recovery from training," "support fat loss alongside diet" — not a compound you read about. The goal determines the compound, and it also determines whether a peptide is even the right tool. Many goals are better served by fundamentals (training, protein, sleep) than by any peptide, so the first question is whether a defined gap actually remains after the basics are handled. If it does, you choose the compound whose evidence and mechanism fit that gap.

This order matters because compound-first thinking — "I want to try BPC-157, what's it good for?" — leads to using a peptide in search of a problem, which is how people end up taking unapproved compounds for vague reasons. Goal-first thinking keeps you honest: it forces you to name what success looks like (which you'll need for tracking), to check whether the evidence supports the compound for that goal, and to confirm a peptide is the appropriate lever at all. Our compound guides — like the BPC-157 protocol guide — and the evidence-tier framework are there to match a goal to a realistic option.

Step 2: source and verify

Evidence tier: 3–4 — gray-market sourcing.

With a compound chosen, sourcing is the next step, and for gray-market peptides it's a real task. You're looking for a vendor whose products are third-party tested, with published certificates of analysis, a track record, and pricing that isn't suspiciously low (a red flag for underdosing or counterfeit). The goal is to maximize the odds that the vial contains what it claims — which, in an unregulated market, you cannot take for granted.

Verification ideally happens before you use the product: reading the vendor's certificate of analysis, checking it against an independent test where possible, and being willing to pay a modest premium over the cheapest listing for that assurance. Beginners most often go wrong here by optimizing for price and receiving a substandard or fake product, then blaming the compound when the real problem was the source. Treating verification as a required part of the first cycle — not an optional extra — is the habit that prevents this. Our how to verify a peptide vendor guide, certificate of analysis guide, and Finnrick cover the how; the pricing red-flags article covers what to avoid.

Step 3: reconstitute and calculate the dose

Evidence tier: 3–4 — dosing accuracy.

Most peptides arrive as a freeze-dried powder requiring reconstitution with bacteriostatic water before dosing, and this step trips up more beginners than any other because it involves arithmetic. You decide how much water to add, which sets the concentration; then you calculate how many units to draw on an insulin syringe to deliver your target dose. Get the math wrong and you can be off by a large factor in either direction — a real problem with a potent compound.

The discipline is to treat the calculation as deliberate, not approximate. The relationships are deterministic: a known amount of peptide plus a known amount of water gives a known concentration, and that concentration plus a target dose gives a specific draw volume. Working it out carefully — ideally checking it against a reconstitution calculator and double-checking before the first dose — eliminates the most common and most consequential first-cycle error. Our peptide reconstitution and dosing guide walks through the math with worked examples; spend the time here, because precision at this step is what makes everything downstream meaningful.

Step 4: inject, then run the cycle

Evidence tier: 3 — technique and duration.

Most peptides are injected subcutaneously, into the fat under the skin, with a small insulin needle — the same routine technique used for insulin. The non-negotiables are aseptic: clean hands, an alcohol-swabbed site, a fresh sterile needle every time, site rotation to avoid irritation, and safe sharps disposal. Done this way, subcutaneous self-injection is low-risk; the main hazard is infection from poor hygiene, not the injection itself (Dolan 2016). Our injection technique for beginners article covers the step-by-step.

Then you run the cycle for a sensible duration tied to the goal and compound. For a course-based peptide (like a recovery peptide), that means running it for the healing window and stopping when the goal is met or progress plateaus, not indefinitely. For a tolerance-prone peptide, it means a duration that respects how the effect holds up over time. The key beginner principles are to start at a reasonable dose rather than the highest one discussed, to not escalate to chase an effect, and to let the goal and the tracking — not a forum number — set the length. Our cycling cornerstone covers how duration should match the compound's mechanism.

A first cycle is also where you should be most alert to anything feeling off. A strong injection-site reaction beyond mild local redness, an unexpected systemic symptom, or anything that worries you is a reason to pause and reassess rather than push through — and, where one is involved, to contact a clinician. Beginners sometimes treat side effects as something to tough out; on an unapproved compound with no oversight, the wiser default is caution, stopping to investigate rather than continuing on the assumption it'll pass. A first cycle is for learning how your body responds, which means erring toward stopping and checking when something is unexpected.

Step 5: track and evaluate

Evidence tier: 2–3 — measurement and honest assessment.

Throughout the cycle, track the target outcome — the specific thing you defined in step one — along with the dose and date. This log is what makes the cycle interpretable: it lets you separate a real effect from placebo and normal variation, notice a fading effect if the peptide is tolerance-prone, and judge at the end whether the goal was actually met. Without tracking, "did it work?" collapses into impression, which is unreliable for subjective outcomes.

At the cycle's end, the log drives an honest evaluation. If the goal was met (the injury healed, the recovery improved, the metric moved), the cycle did its job — and for a course-based compound, that's your cue to stop, not to continue out of habit. If nothing happened, that's important information too: maybe the compound doesn't work for you, maybe the source was bad, or maybe a peptide was the wrong tool and the fundamentals deserve the attention. Either way, you finish with evidence rather than a vague feeling, which is exactly what lets a first cycle inform good decisions about whether to repeat, adjust, or move on. Pairing tracking with appropriate bloodwork, covered in our labs before and during peptides article, strengthens that evaluation further.

Limitations

This is an educational guide, not medical advice or a protocol.

• Peptides are largely unapproved and gray-market — used without regulatory safety nets.
• Goal-first, not compound-first — confirm a peptide is even the right tool.
• Verification and dosing math are required steps, not optional extras.
• Sterile injection technique is essential — infection risk comes from poor hygiene.
• Let the goal and tracking set the duration, not a forum number; don't dose-chase.
• Gray-market sourcing carries real risk — verify via Finnrick.
• Marko Maal, MSc Pharmacy reviewed this article. Reviewer attribution does not constitute a doctor-patient relationship.

The bottom line

A first peptide cycle is a sequence of deliberate steps, not a leap of faith. Define a specific goal and confirm a peptide is the right tool for it, then choose the compound; source from a tested vendor and verify before use; reconstitute and calculate the dose carefully, since dosing math is the most common first-cycle error; inject with sterile technique, where the real risk is infection from poor hygiene; run a sensible duration tied to the goal and the compound's mechanism; and track the outcome so you can evaluate honestly at the end. Each step done carefully is what separates a sensible first cycle from a risky guess.

The mindset that makes a first cycle go well is to treat it as a controlled experiment you're running on yourself, with you filling the quality-control, dosing, and tracking roles that a regulated system normally provides. That means going slow, getting each step right, keeping expectations calibrated to the often-thin evidence, and finishing with real data about whether it worked. Beginners who approach it this way avoid the common pitfalls — bad sourcing, dosing errors, dose-chasing, indefinite use — and come away able to make an informed decision about what, if anything, to do next. Define the goal, respect each step, track honestly, and let the result rather than the hype guide you forward.

Related on this site

• Peptides for beginners (cornerstone)
• Labs to run before and during peptides
• Peptide injection technique for beginners
• Common beginner peptide mistakes
• Peptide reconstitution and dosing guide
• Peptide cycling and breaks (cornerstone)
• Our evidence-tier framework
• Finnrick vendor testing

References

• Frid AH, Kreugel G, Grassi G, et al. 2016. New insulin delivery recommendations. Mayo Clin Proc. 91(9):1231-1255. PMID 27594187 — subcutaneous self-injection technique.
• Dolan SA, Arias KM, Felizardo G, et al. 2016. APIC position paper: Safe injection, infusion, and medication vial practices. Am J Infect Control. 44(7):750-757. PMID 27317519 — aseptic injection practices.
• U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. FDA.gov — regulatory status context for unapproved peptides.